Lonza chair Albert Baehny takes over as in...Swiss Lonza announced that CEO Marc Funk is leaving the company. Chairman Albert Baehny will take over as CEO on an ad interim basis until a successor is found. more ➔
Nosopharm: Chair with experienceNosopharm, a company dedicated to the research and development of new anti-infective drugs, has named Jacques Biton as its new chairman of the board, taking over from Gilles Alberici. more ➔
Santhera nabs CEO from Vifor Swiss specialty pharmaceutical company Santhera has named Dario Eklund as new CEO. Eklund joins from Vifor Pharma, where he served as Chief Commercial Officer. more ➔
Oxford BioDynamics: Decorated board memberRenowned immunologist Iain McInnes has been appointed to the Scientific Advisory Boar of Oxford BioDynamics Plc, where he joins Karol Sikora, Jane Mellor and Lucien Peng-Jin Ooi. more ➔
Recipharm founder to lead Amarna boardAmarna Therapeutics has appointed a new Supervisory Board, led by healthcare and biotech pioneer Thomas Eldered. more ➔
EIT Innovator Award: Marc Julien awardedDiabeloop CEO Marc Julien has won the EIT Innovators Award. more ➔
iOmx: Papadimitriou at the helmiOmx Therapeutics AG has named Apollon Papadimitriou as Chief Executive Officer. more ➔
QIAGEN: Temporary CEOAfter the departure of Peer Schatz, Thierry Bernard is taking over as interim Chief Executive Officer at QIAGEN while the molecular diagnostics company is looking for a permanent head. more ➔
Oerth Bio: Joint venture CEOJohn Dombrosky is taking over the helm of the newly founded Oerth Bio, a targeted protein degradation joint venture launched by Bayer and US biotech Arvinas. more ➔
Solentim: Blending biology and businessIt is a brand-new role at Bournemouth-based Life Sciences company Solentim: Mark Stockdale will join the global leader in cell line development instrumentation as as Amalgamator of Business and Bi … more ➔
